Table 3.
Immune markers | IE single people β | IE in a relationship β | Index of moderated mediation β (Boot SE) | [95% BC CI] |
---|---|---|---|---|
CD3+ number | 0.07 | −0.01 | −0.08 (0.26) | [-0.40 to 0.56] |
CD3+ ratio | 0.01 | −0.05 | −0.06 (0.20) | [-0.41 to 0.43] |
CD16+ number | 0.21 | 0.00 | −0.21 (0.36) | [-0.80 to 0.43] |
CD16+ ratio | 0.07 | 0.00 | −0.07 (0.25) | [-0.43 to 0.41] |
CD56+ number | 0.05 | −0.01 | −0.06 (0.28) | [-0.48 to 0.58] |
CD56+ ratio | 0.00 | −0.04 | −0.04 (0.16) | [-0.31 to 0.24] |
CD16/56+ number | 0.20 | −0.01 | −0.20 (0.45) | [-1.06 to 0.39] |
CD16/56+ ratio | 0.06 | −0.02 | −0.08 (0.37) | [-0.45 to 0.36] |
Neutrophils, absolute count | 0.02 | −0.04 | −0.06 (0.14) | [-0.30 to 0.24] |
Neutrophils, percentage | 0.00 | −0.02 | −0.0 (0.19) | [-0.40 to 0.69] |
Note. Standardized beta (β) quantifies the variation of the dependent variable, in standard deviation, associated with each increase of one standard deviation on the independent variable, through the mediator. N = 44 for all analyses except the percentage of neutrophils for which N = 39.
∗ Effects are significant when confidence intervals (CI) exclude zero.